Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential-Reference-Cited by-同舟云学术

Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential

Published:2024-03 Issue:1 Volume:35 Page:102146
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Gubu Amu,Ma Yuan^ORCID,Yu Sifan,Zhang Huarui,Chen Zefeng,Ni Shuaijian,Abdullah Razack,Xiao Huan,Zhang Yihao,Dai Hong,Luo Hang,Yu Yuanyuan,Wang Luyao,Jiang Hewen,Zhang Ning,Tian Yuan,Li Haitian,Lu Aiping,Zhang Baoting,Zhang Ge

Funder

National Natural Science Foundation of China

Guangdong Provincial Applied Science and Technology Research and Development Program

Publisher

Elsevier BV

Reference27 articles.

1. Therapeutic Potential of Aptamer-Protein Interactions;Shraim;ACS Pharmacol. Transl. Sci.,2022

2. Strategies to manipulate the performance of aptamers in SELEX, post-SELEX and microenvironment;Qi;Biotechnol. Adv.,2022

3. Precise selection of aptamers targeting PD-L1 positive small extracellular vesicles on magnetic chips;Dong;Chem. Commun.,2021

4. Novel and investigational therapies for wet and dry age-related macular degeneration;Sarkar;Drug Discov. Today,2022

5. Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents;Kumar Kulabhusan;Pharmaceutics,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design;European Journal of Medicinal Chemistry;2024-05